Accendra Health (ACH) COO receives 108,696-share restricted stock award

Rhea-AI Filing Summary

Bernocchi Perry A reported acquisition or exercise transactions in this Form 4 filing.

Accendra Health executive Perry A. Bernocchi, EVP and Chief Operating Officer, received a grant of 108,696 shares of Common Stock as equity compensation. The restricted stock grant vests one-third per year over three years. Following this award, his directly held stake totals 342,662 shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bernocchi Perry A

(Last) (First) (Middle)

ACCENDRA HEALTH, INC.

4435 WATERFRONT DRIVE

(Street)

GLEN ALLEN VA 23060

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ACCENDRA HEALTH INC/VA/ [ ACH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	03/09/2026		A		108,696	A	$0	342,662	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock grant which vests one-third per year over three years.

	Perry A. Bernocchi, by Rosemarie France POA	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Accendra Health (ACH) report for Perry A. Bernocchi?

Accendra Health reported an equity grant to Perry A. Bernocchi. He received 108,696 shares of Common Stock as a restricted stock award, recorded as an acquisition rather than an open-market purchase, reflecting part of his executive compensation package at the company.

How many Accendra Health (ACH) shares were granted to Perry A. Bernocchi?

Perry A. Bernocchi was granted 108,696 shares of Common Stock. These shares were issued at a stated price of $0.0000 per share as a restricted stock award, increasing his directly held position to a total of 342,662 shares after the transaction.

What is the vesting schedule for Perry A. Bernocchi’s Accendra Health (ACH) restricted stock?

The restricted stock vests over three years. According to the filing footnote, the 108,696-share grant vests in equal installments, with one-third of the award vesting each year over a three-year period, subject to the grant’s ongoing vesting conditions.

Was Perry A. Bernocchi’s Accendra Health (ACH) transaction an open-market stock purchase?

No, it was not an open-market purchase. The Form 4 classifies the transaction under code A as a grant, award, or other acquisition, with a transaction price of $0.0000 per share, indicating an equity compensation grant rather than a market trade.

How many Accendra Health (ACH) shares does Perry A. Bernocchi hold after this grant?

After the grant, Perry A. Bernocchi holds 342,662 shares directly. The Form 4 shows this total share count following the 108,696-share restricted stock award, providing an updated view of his direct ownership position in Accendra Health.

What does transaction code "A" mean in Perry A. Bernocchi’s Accendra Health (ACH) Form 4?

Transaction code "A" indicates a grant or award acquisition. In this case, it reflects a restricted stock grant of 108,696 shares, received as compensation, rather than a purchase or sale made by Bernocchi in the open market.